Overview

UDCA for Symptomatic Gallstone Disease

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
We conduct a randomized, double-blind, placebo-controlled trial on effects of UDCA on biliary pain and complications in highly symptomatic gallstone patients scheduled for cholecystectomy. We also evaluate potential beneficial effects of impaired gallbladder motility
Phase:
Phase 4
Details
Lead Sponsor:
UMC Utrecht
Collaborators:
Agis Zorgverzekeringen
Dr. Falk Pharma GmbH
Dutch Digestive Diseases Foundation
ZonMw: The Netherlands Organisation for Health Research and Development
Treatments:
Ursodeoxycholic Acid